from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2911/dacB2

LFCtreatmentdescriptionclass of inhibitor

0.636

Amikacinug/mL Amikacintranslation

1.263

Cap5-10ug/mL Capreomycintranslation

2.054

Rox10-50 ug/mL Roxithromycintranslation

0.846

SM2-5 ug/mL Streptomycintranslation

1.027

Tet5-10 ug/mL Tetracyclinetranslation

0.582

Rif0.2-5ug/mL Rifampicintranscription

-0.104

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.132

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.130

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.823

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.059

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.207

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.422

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.443

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.210

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.552

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.004

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.722

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.554

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.429

KCN5-20 ug/mL Potassium cyaniderespiration

-0.293

NaN30.2-2 mM Sodium aziderespiration

-0.011

Nigericin50 uM Nigericinrespiration

-0.578

TRC10-150 ug/mL Triclosanrespiration

-1.715

TRZ10-25 ug/mL Thioridazinerespiration

-1.133

Valinomycin0.5-10 uM Valinomycinrespiration

0.463

ZnSO42 mM ZnSO4respiration

0.442

menadione6-10 ug/mL Menadionerespiration

-0.086

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.553

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.175

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.478

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.222

NRP_1Non-replicating persistence stage 1dosRassociated

0.133

Amp0.2mg/mL AmpicillincellWall

0.160

Cephalexin20-100 ug/mL CephalexincellWall

1.044

Cerulenin0.32-5 ug/mL CerulenincellWall

0.672

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.571

EMB10-20 ug/mL EthambutolcellWall

1.096

Eta12-40 ug/mL EthionamidecellWall

1.161

INH0.2-0.4 ug/mL IsoniazidcellWall

0.535

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.191

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.905

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.276

BZA0.12 mg/mL BenzamidearomaticAmides

0.284

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.955

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.023

H2O24 mM hydrogen peroxideDNAdamaging

-0.121

Levo10 ug/mL LevofloxacinDNAdamaging

0.086

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.554

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.139

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.310

UVUV-irradiationDNAdamaging

-0.951

ARP41-4 ug/mL Antitubercular compound ARP4?

0.717

Antimycin12.5-50 ug/mL Antimycin A?

0.568

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.531

PA_110-50 ug/mL Antitubercular compound PA-1?

0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.268

PA8240.2-2 ug/mL PA-824?

-0.927

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.131

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.149

Verapamil50 uM Verapamil?

0.217

mercaptoethanol2 mM 2-Mercaptoethanol?

0.431

methoxatin10-20 ug/mL Methoxatin?